Showing results (111-120 of 130) with videos related to

Sort By:
Pageof 13
Practical Radiation Oncology|June 11, 2025
CLINICIAN- AND PATIENT-REPORTED OUTCOMES OF STEREOTACTIC ABLATIVE RADIOTHERAPY FOR HIGH-RISK PROSTATE CANCERHelena Bz Logar, Angel Montero, Ovidio Hernando, et al.
Journal of the International AIDS Society|November 15, 2014
ACTG-HIV symptoms changes in patients switched to RPV/FTC/TDF due to previous intolerance to CART. Interim analysis of the PRO-STR studyDaniel Podzamczer, Nerea Rozas, Pere Domingo, et al.
The Prostate|November 7, 2012
Polymorphisms in CYP17 and CYP3A4 and prostate cancer in men of African descentEmanuela Taioli, Vestra Sears, Alexis Watson, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|April 14, 2023
Stereotactic body radiation therapy (SBRT) for spinal metastases: 12 years of a single center experienceRaquel Ciérvide, Ovidio Hernando, Mercedes López, et al.
Nature Communications|September 27, 2024
Computer-aided drug design to generate a unique antibiotic familyChristopher J Barden, Fan Wu, J Pedro Fernandez-Murray, et al.
The Journal of Experimental Medicine|December 7, 2017
Short Aβ peptides attenuate Aβ42 toxicity in vivoBrenda D Moore, Jason Martin, Lorena de Mena, et al.
The Journal of Biological Chemistry|March 12, 2011
Amyloid-beta42 interacts mainly with insoluble prion protein in the Alzheimer brainWen-Quan Zou, Xiangzhu Xiao, Jue Yuan, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 15, 2025
Single and multitarget stereotactic radiosurgery (SRS) with single isocenter in the treatment of multiple brain metastases (BM): institutional experienceRaquel Ciérvide, Jaime Martí, Mercedes López, et al.
Nature Communications|March 24, 2022
Mechanism of action and therapeutic route for a muscular dystrophy caused by a genetic defect in lipid metabolismMahtab Tavasoli, Sarah Lahire, Stanislav Sokolenko, et al.
Plos One|May 4, 2017
A KCNC3 mutation causes a neurodevelopmental, non-progressive SCA13 subtype associated with dominant negative effects and aberrant EGFR traffickingSwati Khare, Jerelyn A Nick, Yalan Zhang, et al.
Pageof 13